Tarveda Therapeutics, Inc. — Form D

Tarveda Therapeutics, Inc. of WATERTOWN, MA, a company, filed a Form D exempt-offering notice with the SEC on 2017-02-09. The offering totals $30.0M, of which $30.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (46)

Showing 25 of 46 people.

NameRoleLocation
Dennis S AusielloDirectorWatertown, MA
James J BarrettDirectorWatertown, MA
Robert S Langer, Jr.DirectorWatertown, MA
Guido S MagniDirectorWatertown, MA
Aymeric S SallinDirectorGaithersburg, MD
Frank S TortiDirectorWatertown, MA
Leila J AllandExecutive OfficerWatertown, MA
Richard J WoosterExecutive OfficerWatertown, MA
James BarrettDirectorRichmond, VA
Dennis AusielloDirectorSan Jose, CA
Andrew FromkinDirectorNew York, NY
Andrew FromkinExecutive OfficerNew York, NY
Aymeric SallinDirectorSanta Clara, CA
Peter Barton HuttDirectorSalt Lake City, UT
Brian RobertsDirectorNew York, NY
Brian RobertsExecutive OfficerNew York, NY
Michael MetzgerDirectorWatertown, MA
Nilesh KumarDirectorWatertown, MA
Guido MagniDirectorWatertown, MA
Robert J LangerDirectorWoburn, MA
Aymeric J SallinDirectorWatertown, MA
Nilesh J KumarDirectorWatertown, MA
Guido J MagniDirectorWatertown, MA
Omid J FarokhzadDirectorWatertown, MA
Andrew J FromkinDirectorWatertown, MA

Other filings by this issuer (9)

FiledFormOfferingSold
2021-09-27D$6.0M$6.0M
2020-12-28D$15.4M$15.0M
2019-12-26D$13.6M$13.6M
2017-02-09D/A$38.0M$38.0M
2016-01-29D$38.0M$25.5M
2014-03-12D$1000K$1000K
2013-12-24D/A$21.0M$21.0M
2012-12-20D$21.0M$16.0M
2011-09-02D$2.8M$2.8M

More